Company profile
Uncommon
We’re using ground-breaking cell technologies to revolutionise global food production - starting with pork
- Industry
- Biotechnology Research
- Employees
- 8
- Headquarters
- Cambridge, England
- Founded
- 2017
- LinkedIn followers
- 9,885
- Office locations
- 1
Uncommon company summary
Uncommon is a company in the Biotechnology Research industry, headquartered in Cambridge, England, founded in 2017. On LinkedIn the company has around 8 employees and 9,885 followers. Its listed specialties include science+art, biotech, mRNA, IPF, Pulmonary fibrosis.
What technology does Uncommon use?
No technologies detected yet. Warmrank rechecks company websites on a rolling basis.
About Uncommon
Uncommon Bio began with cell-based meat and pioneered RNA delivery innovations, which evolved into their most recent spin out which is focusing on changing medicine through multi-targeting. Their polysaccharide-based delivery platform enables multi-pathway cell programming, offering a safe, efficient and scalable alternative to multi-target therapies. The company is initially targeting severe lung diseases like idiopathic pulmonary fibrosis and is backed by industry leaders from BioNTech and top investors, including Sam Altman, Balderton, Lowercarbon, and Redalpine.
Specialties
Where is Uncommon located?
Uncommon lists 1 location.
Compare companies similar to Uncommon
More companies in Biotechnology Research.
| Company | Industry | Employees | Founded | Headquarters |
|---|---|---|---|---|
Uncommon uncommonbio.co | Biotechnology Research | 8 | 2017 | Cambridge, England |
 Thermo Fisher Scientific thermofisher.com | Biotechnology Research | 100,779 | - | Waltham, MA |
 Amgen amgen.com | Biotechnology Research | 41,028 | 1980 | Thousand Oaks, CA |
 Biogen biogen.com | Biotechnology Research | 7,742 | - | Cambridge, MA |
 Biocon biocon.com | Biotechnology Research | 11,902 | - | Bangalore, Karnataka |
| Biotechnology Research | 28,679 | - | Bethesda, MD | |
 Genentech gene.com | Biotechnology Research | 18,296 | 1976 | South San Francisco, California |
 Eurofins eurofins.com | Biotechnology Research | 24,928 | - | Luxembourg, Luxembourg |
 Gilead Sciences gilead.com | Biotechnology Research | 14,743 | - | Foster City, CA |
 Syneos Health syneoshealth.com | Biotechnology Research | 23,772 | - | Morrisville, NC |
 Moderna modernatx.com | Biotechnology Research | 6,238 | 2010 | Cambridge, Massachusetts |
Frequently asked questions about Uncommon
What does Uncommon do?
Uncommon Bio began with cell-based meat and pioneered RNA delivery innovations, which evolved into their most recent spin out which is focusing on changing medicine through multi-targeting. Their polysaccharide-based delivery platform enables multi-pathway cell programming, offering a safe, efficient and scalable alternative to multi-target therapies. The company is initially targeting severe lung diseases like idiopathic pulmonary fibrosis and is backed by industry leaders from BioNTech and top investors, including Sam Altman, Balderton, Lowercarbon, and Redalpine.
How many employees does Uncommon have?
Uncommon has around 8 employees on LinkedIn.
Where is Uncommon headquartered?
Uncommon is headquartered in Cambridge, England.
When was Uncommon founded?
Uncommon was founded in 2017.
Build a lead list from companies like Uncommon
Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.